Fresenius Medical Care AG & Co. KGaA (FMS) Stock Forecast
FMS analyst forecast
as of October 18, 2026- Analyst consensus
- Hold 2.71 / 5 from 7 analysts
- Price target
- $23.95 average of analyst targets
- Upside to target
- +8.0% from the latest close
- Next earnings
- November 3, 2026 EPS estimate $0.51
- 52-week range
- $20.19 – $27.37
FMS analyst ratings
7 analystsNumber of analysts at each rating.
FMS price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
FMS earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.51 | $0.47 | $0.55 | $0.55 | −7.7% | 2 |
| Current fiscal year (2026) | $2.09 | $1.96 | $2.22 | $2.14 | −2.4% | 4 |
| Next fiscal year (2027) | $2.67 | $2.08 | $4.51 | $2.09 | +27.9% | 5 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
FMS revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $4.94B | $4.85B | $5.03B | +1.1% | 5 |
| Current fiscal year (2026) | $19.46B | $19.04B | $20.16B | −0.8% | 17 |
| Next fiscal year (2027) | $20.10B | $19.46B | $20.64B | +3.3% | 16 |
FMS EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
FMS revenue: reported and forecast
FMS EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.57 | $0.50 | $0.50 | $0.51 | $0.51 | −10.7% | 1 up · 0 down |
| Current fiscal year (2026) | $2.45 | $2.07 | $2.07 | $2.08 | $2.09 | −14.7% | 1 up · 0 down |
| Next fiscal year (2027) | $3.17 | $3.14 | $3.14 | $2.67 | $2.67 | −15.8% | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
FMS earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; FMS beat in 9 of 12.
What analysts expect from FMS
7 analysts cover Fresenius Medical Care AG & Co. KGaA; their consensus rating is hold (2.71 on a 1–5 scale, where 5 is a strong buy). The average price target is $23.95, 8.0% above the latest close of $22.17. Analysts expect earnings of $2.09 per share for 2026, −2.4% from a year earlier. For 2027 the average estimate is $2.67 per share on revenue of $20.1 billion. Fresenius Medical Care AG & Co. KGaA beat the EPS estimate in 9 of the last 12 quarters.
Related: FMS income statement, FMS key metrics, FMS chart. See the FMS stock overview for the latest quote and news.
FMS forecast FAQ
What is Fresenius Medical Care AG & Co. KGaA's price target?
The average analyst price target for Fresenius Medical Care AG & Co. KGaA is $23.95, 8.0% above the latest close of $22.17.
Is Fresenius Medical Care AG & Co. KGaA a buy, hold or sell?
Of 7 analysts covering Fresenius Medical Care AG & Co. KGaA, 1 rate it a strong buy, 0 a buy, 3 a hold, 2 a sell and 1 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.
What is Fresenius Medical Care AG & Co. KGaA's EPS forecast?
Analysts forecast $2.09 per share for 2026 (range $1.96 to $2.22); for 2027 the estimate is $2.67.
What is Fresenius Medical Care AG & Co. KGaA's revenue forecast?
The average revenue estimate for 2026 is $19.5 billion, growth of −0.8%; for 2027 it is $20.1 billion.
When does Fresenius Medical Care AG & Co. KGaA report earnings?
Fresenius Medical Care AG & Co. KGaA is expected to report results for the quarter ending September 30, 2026 on November 3, 2026 before the market opens; the EPS estimate is $0.51.
Does Fresenius Medical Care AG & Co. KGaA usually beat earnings estimates?
Fresenius Medical Care AG & Co. KGaA reported EPS at or above the analyst estimate in 9 of the last 12 quarters.